General Information of the Compound
| Compound ID |
CP0133378
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[5-[1-(furan-2-ylcarbonyl)piperidin-3-yl]-1,2,4-oxadiazol-3-yl]-N-(phenylmethyl)benzenesulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H24N4O5S
|
||||||||||||||||||
| Molecular Weight |
492.557
|
||||||||||||||||||
| Canonical SMILES |
O=C(N1CCCC(C1)c1nc(no1)-c1ccc(cc1)S(=O)(=O)NCc1ccccc1)c1ccco1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H24N4O5S/c30-25(22-9-5-15-33-22)29-14-4-8-20(17-29)24-27-23(28-34-24)19-10-12-21(13-11-19)35(31,32)26-16-18-6-2-1-3-7-18/h1-3,5-7,9-13,15,20,26H,4,8,14,16-17H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZPIQTKFMNQCPAX-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02997, Isocitrate dehydrogenase [NADP] cytoplasmic
Protein ID: PT06172, Mothers against decapentaplegic homolog 3